ArticlePoultry science2026
Detection of PPMV-1 antibodies in pigeons using a blocking ELISA based on an NP-specific monoclonal antibody.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pigeon paramyxovirus type 1 (PPMV-1) is a prevalent infectious agent causing Newcastle disease in pigeons, yet serological methods for detecting PPMV-1-specific antibodies remain limited. In this study, we developed a blocking enzyme-linked immunosorbent assay (ELISA) based on a monoclonal antibody (mAb) targeting the nucleocapsid (NP) protein of PPMV-1. The B-cell epitopes of the NP protein were computationally predicted, and the core antigenic domain was expressed in Escherichia coli and purified to generate specific mAbs. Following hybridoma technology, a high-affinity mAb (6B8) was produced and used to establish the blocking ELISA. Assay conditions were systematically optimized using checkerboard titration, including antigen concentration, serum dilution, incubation time, blocking buffer, and blocking duration. Analysis of known pigeon serum samples established a cut-off value of 26.87% inhibition (PI%), with an analytical sensitivity of 1:400, representing the highest dilution at which all tested positive sera remained detectable. The assay showed no cross-reactivity with other common avian pathogens, except for limited cross-reaction with Newcastle disease virus La Sota strain. Intra- and inter-batch coefficients of variation were all below 10%. Clinical validation using 86 pigeon serum samples demonstrated a concordance rate of 97.67% (84/86) compared with the hemagglutination inhibition (HI) test. In conclusion, this monoclonal antibody-based blocking ELISA provides a sensitive, specific, and reliable tool for large-scale serological surveillance of PPMV-1 in pigeons.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.